Jim Simons’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $186K | Sell |
27,481
-4,200
| -13% | -$32.9K | ﹤0.01% | 2928 |
|
|
2025
Q4 | $278K | Buy |
31,681
+2,400
| +8% | +$23.5K | ﹤0.01% | 2785 |
|
|
2025
Q3 | $359K | Buy |
29,281
+18,100
| +162% | +$170K | ﹤0.01% | 2932 |
|
|
2025
Q2 | $59.3K | Sell |
11,181
-8,070
| -42% | -$58.9K | ﹤0.01% | 3370 |
|
|
2025
Q1 | $149K | Sell |
19,251
-35,097
| -65% | -$421K | ﹤0.01% | 3133 |
|
|
2024
Q4 | $719K | Buy |
54,348
+24,222
| +80% | +$225K | ﹤0.01% | 2666 |
|
|
2024
Q3 | $301K | Buy |
+30,126
| New | +$455K | ﹤0.01% | 2980 |
|
|
2024
Q2 | – | Sell |
-6,660
| Closed | -$391K | – | 3642 |
|
|
2024
Q1 | $391K | Sell |
6,660
-20,676
| -76% | -$891K | ﹤0.01% | 2970 |
|
|
2023
Q4 | $606K | Buy |
27,336
+25,096
| +1,120% | +$379K | ﹤0.01% | 2698 |
|
|
2023
Q3 | $48K | Buy |
+2,240
| New | +$88K | ﹤0.01% | 3410 |
|
|
2023
Q2 | – | Sell |
-3,336
| Closed | -$1.56M | – | 4034 |
|
|
2023
Q1 | $1.56M | Sell |
3,336
-8,888
| -73% | -$4.7M | ﹤0.01% | 2183 |
|
|
2022
Q4 | $4.9M | Sell |
12,224
-19,576
| -62% | -$7.5M | 0.01% | 1535 |
|
|
2022
Q3 | $10.3M | Buy |
31,800
+1,572
| +5% | +$506K | 0.01% | 1014 |
|
|
2022
Q2 | $7.98M | Buy |
30,228
+2,712
| +10% | +$693K | 0.01% | 1238 |
|
|
2022
Q1 | $8.27M | Buy |
27,516
+23,552
| +594% | +$8.21M | 0.01% | 1242 |
|
|
2021
Q4 | $1.4M | Sell |
3,964
-4,382
| -53% | -$1.36M | ﹤0.01% | 2418 |
|
|
2021
Q3 | $2.13M | Buy |
+8,346
| New | +$2.96M | ﹤0.01% | 2038 |
|
|
2021
Q2 | – | Sell |
-1,260
| Closed | -$1.09M | – | 3556 |
|
|
2021
Q1 | $1.09M | Buy |
1,260
+608
| +93% | +$647K | ﹤0.01% | 2574 |
|
|
2020
Q4 | $605K | Buy |
+652
| New | +$685K | ﹤0.01% | 2740 |
|
|
2020
Q3 | – | Sell |
-13,888
| Closed | -$14.1M | – | 3463 |
|
|
2020
Q2 | $14.1M | Buy |
+13,888
| New | +$12.9M | 0.01% | 1021 |
|
|
2018
Q2 | – | Sell |
-6,696
| Closed | -$7.73M | – | 3350 |
|
|
2018
Q1 | $7.73M | Sell |
6,696
-5,668
| -46% | -$7.46M | 0.01% | 1538 |
|
|
2017
Q4 | $14.7M | Buy |
12,364
+404
| +3% | +$507K | 0.02% | 1155 |
|
|
2017
Q3 | $16.1M | Buy |
11,960
+2,868
| +32% | +$3.02M | 0.02% | 1023 |
|
|
2017
Q2 | $7.34M | Sell |
9,092
-7,712
| -46% | -$5.37M | 0.01% | 1457 |
|
|
2017
Q1 | $10.4M | Buy |
16,804
+3,500
| +26% | +$2.13M | 0.01% | 1222 |
|
|
2016
Q4 | $7.12M | Buy |
13,304
+4,372
| +49% | +$2.18M | 0.01% | 1455 |
|
|
2016
Q3 | $4.62M | Buy |
+8,932
| New | +$4.21M | 0.01% | 1648 |
|
Other funds holding KYNB
AC
VCM
VFT
BC
Jim Simons's KYNB Position: Q1 2026 in Review
Jim Simons reduced its Kyntra Bio (KYNB) stake by 13% in Q1 2026, selling an estimated $32.9K and leaving 27,481 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #2928.
Jim Simons first reported a position in KYNB in Q3 2016 and has held it in 27 quarters since. The position peaked at $16.1M in Q3 2017. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.
- Jim Simons held 27,481 shares of Kyntra Bio worth $186K as of Q1 2026.
- Jim Simons sold 4,200 Kyntra Bio shares in Q1 2026, an estimated $32.9K.
- Kyntra Bio made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2928 holding.
- Jim Simons first reported a position in Kyntra Bio in Q3 2016 and has held it in 27 quarters since.
- Jim Simons's Kyntra Bio position peaked at $16.1M in Q3 2017.
- 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.